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PEDIATRIC OPIOID ENDEMIC
ABSTRACT
Introduction
As of 2017, 54 out of every 1,000 children born in West Virginia were affected by opioid use.
NAS Centers provided care to infants who have been diagnosed with, or have been vulnerable to
develop, NAS. The purpose of this research study reviewed the Pediatric Opioid Endemic
happening in West Virginia and determined if NAS programs and prenatal opioid maintenance
therapy would increase access to NAS patients and decrease the cost of treatments.
Methodology
The methodology was a literature review. Thirty-nine sources were referenced for this literature
from 2010-2020.
Results
This review examined sources of the Pediatric Opioid Endemic in West Virginia. This review
focused on NAS programs and how prenatal opioid maintenance therapy can increase access to
NAS Patients. This decreased the number of infants diagnosed with NAS and decreased the cost
of treatments for infants and mothers.
Discussion/Conclusion
The purpose of this research paper was that NAS Centers and prenatal opioid maintenance
therapy would help improve the pediatric opioid endemic by decreasing the number of NAS
patients and decrease the cost of treatments for infants. The review explored research and an
expert in NAS therapy was conducted. The results from this showed that NAS Centers offering
therapy to both mother and patients will decrease the amount of infants diagnosed with NAS and
decrease the cost of treatments.
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INTRODUCTION
Neonatal Abstinence Syndrome (NAS) has been described as a postpartum drug withdrawal
condition that typically transpires among opioid-exposed newborns following birth (Ko, et al,
2016). Opioids have been defined as prescribed or illegal classes of drugs utilized to decrease
pain (CDC, 2018). NAS has been associated with central nervous system sensitivity, autonomic
hyperactivity, and gastrointestinal issues (Ko, et. al, 2016). NAS has been labelled as a shortterm occurrence that ranges in severity where some infants need treatment while others do not
(NAS, 2017).
Endemic has been referred to as a disease or condition amidst specific people within a
given area (Lexico, 2020). The state with the highest opioid death rate in the nation has been
West Virginia (Cenziper, Corio, Hooper, Soule, 2019). Every 137.6 per 100 people in West
Virginia have been prescribed an opioid (Lilly, et al. 2019). In 2018, West Virginia had 51.5
drug overdose deaths per 100,000 people (Hedegaard, Minino, Warner, 2020). WV has the third
highest age-adjusted death rate from drug poisoning in the country and the third-highest
prescribing rate of opioids (Paulozzi, Mack, Hockenberry, 2014).
As of 2017, 54 out of every 1,000 children born in West Virginia were affected by opioid
use (Knisely, 2019). More specifically, in Bluefield, West Virginia, nearly 3.5% of newborns
were diagnosed with drug withdrawal in 2017 (Patrick, 2019). The crisis is not only happening
across America, but hurting small towns and taking a toll on pregnant women and their babies
(Patrick, 2019). From 2009 to 2015, the number of Medicaid-covered infants in West Virginia
that were diagnosed with NAS was documented at 6 million births, which is higher than any
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other city (Patrick, 2019). The opioid crisis has not only been a healthcare problem, but has
grown into a social problem resulting in babies being treated for drug withdrawal (Patrick, 2019).
West Virginia, Tennessee, and Kentucky have had the highest NAS incidence rates with
1,058 to 4,172 NAS infants per 1,000 births (Wolf, Tong, Sabo, Woolf, Abbinanti, Pecsok, Krist,
2019). NAS has been found typical among 25% of states with high amounts of rural residents
(Wolf, et. al, 2019). While West Virginia has also had the highest incidence of NAS in the
United States (U.S.), 33.4 per 1,000 newborns, the state has also spearheaded strategies to
improve the issue nationwide (Gottlieb, Davies, Wright, 2018).
The public’s focal point has not been on whether the opioid was prescribed by a
healthcare provider for conditions, including pain management or treatment for Opioid Use
Disorder (OUD), or the mother has abused medications and illegal opioids (NAS, 2017). In
2018, Healthy Connections was developed to supply family services, promoted policy change
and increased treatment options, researched and applied procedures, and provided substance use
disorder education (Gottlieb, et. al, 2018).
NAS Centers (NASC) have been described as organizations that deliver care to infants
who have been diagnosed with, or have been vulnerable to develop, NAS (WVDHHR, 2019).
The WVDHHR has received authorization from the U.S. Centers for Medicare and Medicaid
Services (CMS) to offer NAS treatment services, including complete assessments,
Pharmaceutical Withdrawal Treatment, slow presentation of sensory stimuli, and observing
withdrawal objective assessments, and West Virginia was the first state to receive approval
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(WVDHHR, 2018). Due to the opioid epidemic, there have been more drug-addicted babies in
West Virginia compared to any other state and opening up these centers in the state has
established a mechanism that helps fight the opioid epidemic (Hodousek, 2018). The West
Virginia NAC licensure rule has required a NASC to have at least two licensed nurses present
during each period of work (WVDHHR, 2019). NAS centers have offered pharmacological and
non-pharmacological techniques to intervene during the withdrawal process (WVDHHR, 2018).
The Neonatal Therapeutic Unit (NTU) at Hoops Family Children’s Hospital in
Huntington, West Virginia, opened its doors in 2012 with the purpose to care for babies
experiencing NAS (Murray, 2017). Within the first five years, the unit exceeded the 12-bed
capacity and had to allow change to meet the needs of patients and parents (Murray, 2017). The
NTU has been used when babies do not need the services offered in the Neonatal Intensive Care
Unit (NICU), but have found comfort in the NTU staff’s support (Hoops Children’s Hospital,
2020). The NTU has also involved family members in the babies’ care, creating practices that
can be utilized after the hospital stay (Hoops Children’s Hospital, 2020).
In 2014, Lily’s Place was the first NAS center to open in the U.S. in Huntington, West
Virginia, and has received national attention (Null, 2018). Lily’s Place has delivered care to
West Virginia babies experiencing the withdrawal process and families learning the
fundamentals of how to care for a NAS infant (Null, 2018). Cabell Huntington Hospital in West
Virginia had initiated Lily’s Place and Cabell Huntington Hospital’s NTU (Powell, 2019). The
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United States’ first interim care nursery, Pediatric Interim Care Center (PICC), located in Kent,
Washington, was the motivation for the establishment (Powell, 2019).
Lily’s Place has been the first in the state to receive the U.S. Centers for Medicare and
Medicaid Services’ approval for reimbursement for NAS treatments (Snoderly, 2018). The
facility has received funding from the state since opening its doors, covering approximately 60%
of the center’s costs (Snoderly, 2018). In 2018, Lily’s Place received a $500,000 grant from
Pfizer to continue offering advanced neonatal care and support for mothers. The services from
Cabell Huntington Hospital’s MOMs program have been incorporated into Lily’s Place plan-ofcare to ensure comprehensive services are available (The Herald-Dispatch, 2018). Once an infant
has become a Lily’s Place patient, Child Protective Services (CPS) has made certain that family
members, including mothers, have been taking the necessary steps to become clean (Davis,
2016a).
Lily’s Place has influenced federal bills including the NAS Healthy Babies Act (Davis,
2016b). The act has mandated the Government Accountability Office (GAO) to disclose
information on NAS (CRS, 2016). The NAS Healthy Babies Act would have also given
nationwide facilities the opportunity to replicate Lily’s Place (Davis, 2016b). The bill was
introduced on April 18, 2018, to U.S. Congress, but had not been enacted due to dying in a
previous Congress (GovTrack, 2020).
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The purpose of this research study reviewed the Pediatric Opioid Endemic happening in
West Virginia and determined if NAS programs and prenatal opioid maintenance therapy would
increase access to NAS patients and decrease the cost of treatments.

METHODOLOGY
The methodology for this study was literature research and review of case studies and a semistructured interview. The primary hypothesis for this research paper was that NAS Centers and
prenatal opioid maintenance therapy would help improve the pediatric opioid endemic by
decreasing morbidity in NAS patients and decrease the cost of treatments for infants.

Search Strategy
The review utilized in this study about Pediatric Opioid Endemic in West Virginia was
composed of primary and secondary data. The conceptual framework, illustrated by Figure 1, for
this review was adapted from the steps and research used by Morgan and Wang (2019). The
research method was an adoption of the framework showing the linkages between early exposure
to opioids such as maternal prescribed use, a child's subsequent risk for disability, and results of
receiving special education services. Throughout the process assessment, the use of opioid
maintenance and education services among the fetal and infant stages and how they affected the
early childhood stages. The framework explored the exposure to opioids in utero and linked them
to the postnatal effects through environmental contexts. Maternal opioid use has been said to
result in NAS, as well as cognitive, physical, and behavioral impairments. See Figure 1.
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The literature was conducted in three stages: (1) developing a search strategy and
gathering data; (2) determining and analyzing the relevant literature; (3) allotting literature to
appropriate categories.

Step 1: Literature Identification and Collection
When implementing the search, the following keywords were employed: “pediatric
opioid endemic” AND “neonatal abstinence syndrome” OR “NAS” AND “prenatal opioid
maintenance” OR “opioid therapy”. The following electronic databases were utilized to gather
literature: Medline, Access Pharmacy, PubMed and Google Scholar. The Center for Disease
Control and Prevention, National Academy of Sciences, National Institute of Health, and West
Virginia Department of Health and Human Resources were reliable websites that were also
minded in the review. PRISMA was used as an overview for the literature evaluation for
reporting systematic reviews and meta-analyses..The search identified 540 relevant citations and
articles were excluded (N= 506) if they did not meet inclusion principles. Articles were included
(N= 34) if they described the pediatric opioid endemic and NAS centers: articles from other
sources (N=17) were also minded in this search. These 34 references were subject to full-text
review, and these 34 citations were included in the data abstraction and analysis. Only 39
references were used in the results section. (See Figure 2).
A semi-structured interview with an expert was conducted regarding the pediatric opioid
endemic happening in West Virginia. This expert was an Executive Director at Lily’s Place in
Huntington, West Virginia, and was referred to as an expert in NAS. This individual was chosen
for the semi-structured interview due to her high amount of experience in recovery
administration. This semi-structured interview was IRB approved and took place via phone.
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Step 2: Establishment of Inclusion Criteria and Literature Analysis
The Pediatric Opioid Endemic has become important because of its impact on West
Virginia. Therefore ,the literature analyzed focused on the following key areas: Opioid Endemic
in West Virginia, Neonatal Abstinence Syndrome (NAS), Specific Drug Trends, and NAS
therapy. The articles written in the English were published between 2010 and 2020. Thirty-nine
were utilized for this research study. This literature search was conducted by OM and MW and
validated by AC, who acted as the second reader and double checked to ensure that references
met the inclusion criteria.

Step 3: Literature Categorization
The following subheadings were included in the research: Pediatric Opioid Endemic in
West Virginia, NAS and Drug Specific Trends, NAS Centers and NAS Treatment, Prenatal
Opioid Maintenance, and Maintenance Programs.

RESULTS
Pediatric Opioid Endemic in West Virginia
An umbilical cord tissue study was completed in eight West Virginia hospitals, where infants
were tested on the exposure to licit/illicit drugs and alcohol (Lilly, et al. 2019). The study
showed that 20% of the infants had been exposed (Lilly, et al. 2019). In 2010, Charleston Area
Medical Center (CAMC) in West Virginia stated that 1 and 3 women tested positive for opioid
abuse (Harold, 2011). The study included 706 pregnant mothers between July 2010 and July
2011 were tested for drug use and 74% tested positive for marijuana, 20% tested positive for
opioids, 12% tested positive for Benzodiazepines, and 6% tested for Methadone (Harold, 2011).
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Another study completed by Stitely, et al. (2010) tested 759 pregnant women in West Virginia
for drug and alcohol abuse and 146 or 19.2% tested positive.
NAS and Drug Specific Trends
The opioid epidemic has had consequences that have affected pregnant women and NAS
has been diagnosed in 55%-94% of newborns (Nair, Soraisham, and Akierman, 2012). This has
caused health complications during pregnancy for the infant and caused by the use of Heroin,
Codeine, Oxycodone, methadone, and Buprenorphine (Medline Plus, 2017). Hospital charges for
NAS have reached $1.5 billion in 2012, with 81% of the cost being charged to state Medicaid
programs (Patrick, Davis, Lehman, and Cooper, 2015). Between 2004 and 2014, the amount of
NAS cases in West Virginia increased from 1.5 cases per 1,000 births to 8.0 cases per 1,000
hospital births (NIH, 2019). This has been the same as an infant being born with symptoms of
NAS every fifteen minutes (NIH, 2019). Hospital costs for NAS have increased from $91 million
to $563 million due to the increase in the number of cases from 2004- 2014 and an increase from
1.5- 8.0 for NAS incident rates and 150 to 563 million dollar cost inflation.
138,224 out of 55,781965 hospitalizations in pregnant women were due to the opioid
crisis (Krans, Cochran, and Bogen, 2015). More than 35% of the women tested positive for
marijuana, cocaine, benzodiazepines, and 77%-95% had smoked tobacco (Krans, et al, 2015).
A study completed by Stabler, et al. (2018), examined NAS and drug specific trends in
West Virginia by examining 119,605 live births in West Virginia hospitals. It was found that
1,974 of the births were NAS diagnoses and the number of cases diagnosed at birth were 98.4%
of the total cases (Stabler, et al. 2018). The findings from the study showed that NAS rates have
continued to rise in West Virginia (Stabler, et al. 2018). Within the years of 2007 to 2013, the
rate of newborns diagnosed with NAS in West Virginia increased from 1.89 to 8.09 for narcotics,
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the diagnosis of hallucinogen exposure did not change over time, and the diagnosis of cocaine
exposure decreased from 1.77 to 0.74 per 1,000 live births (Stabler, et al. 2018).

NAS Centers and NAS Treatment
NAS centers were created to help treat babies who have been born addicted to drugs,
allowing Lily's Place and the Neonatal Therapeutic Unit (NTU) at Hoops Family Children’s
Hospital to be recognized and treat infants (Hodousek, 2018). Each year, the state Medicaid
program has covered more than $1 billion to care for infants with NAS (Normile and Hanlon,
2018). In February 2018, the Centers for Medicare and Medicaid Services (CMS) approved a
new financing approach to be more cost efficient for state Medicaid programs covering the cost
of NAS treatments (Normile and Hanlon, 2018). The average hospital stay for an infant with
NAS has been 17 days and has cost nearly $93,000 and non-hospital treatments for infants with
less severe cases of NAS have ranged from $600-$2,600 per treatment (Normile and Hanlon,
2018).

Prenatal Opioid Maintenance
Opioid use during pregnancy has increased the risk of NAS in linked to other
complications throughout the pregnancy and has resulted in the infant needing treatment such as
buprenorphine (Nguyen, et al. 2018). Although NAS has been a serious condition, the mothers of
the infants should receive treatment of buprenorphine during and after the pregnancy to quit the
use of drugs. Methadone and buprenorphine have been used to help treat the baby of opioid use
during pregnancy (Nguyen, et al. 2018). Buprenorphine has been a formula used to help limit
fetal exposure due to fetal withdrawal, potential mix of hormones, and behavioral effects
(Nguyen, et al. 2018). Studies have shown that individuals treated with methadone and
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buprenorphine during the pregnancy have infants who are less likely to be diagnosed with NAS,
had a lower peak NAS during treatment, and improved delivery (Wiegand, et al, 2015). The
study included 62 mothers, 31 of those were treated with methadone and the other 31 were
treated with buprenorphine and naloxone. The methadone group had a Neonatal Abstinence
Syndrome (NAS) diagnosis of 51.6% compared to the buprenorphine and naloxone group who
had a NAS diagnosis of 25.1% (Wiegand, et al, 2015).

Maintenance Programs
Drug Free Moms and Babies Program (DFMB) has been a program in West Virginia that
has been offered to mothers and children that suffer from substance abuse (Greenbrier Valley
Medical Center, 2020). The goal of the program has been to have healthier outcomes for the
mother and baby, and this has been done by providing prevention, early intervention, education,
addiction treatment, and recovery support services (Greenbrier Valley Medical Center, 2020).
Medication-Assisted Treatment (MAT) has been the standard care for those with opioid use
disorder and has been the safest, most effective treatment (Greenbrier Valley Medical Center,
2020).
DISCUSSION
The purpose of this research study reviewed the Pediatric Opioid Endemic happening in West
Virginia and determined if NAS programs and prenatal opioid maintenance therapy would
increase access to NAS patients and decrease the cost of treatments. The primary hypothesis for
this research paper was that NAS Centers and prenatal opioid maintenance therapy would help
improve the pediatric opioid endemic by decreasing the number of NAS patients and decrease
the cost of treatments for infants. Results from the literature review have shown that West
Virginia has continued to have an increased number of NAS births and have addressed the issue
12
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by establishing NAS centers such as Lily’s Place, a Neonatal Therapeutic Unit (NTU), and the
Drug Free Moms and Babies Program that have offered NAS services during and after
pregnancies to mothers and babies.
The opioid crisis has developed from a healthcare issue to a social issue nationwide. NAS
has been diagnosed in 55%-94% of newborns. Opioid use during pregnancy has caused
pregnancy issues and have resulted in NAS treatment for the infant. Heroin, Codeine,
Oxycodone, Methadone, and Buprenorphine have produced health difficulties for NAS babies.
By 2012, NAS related charges in hospitals totaled $1.5 billion and 81% was charged to state
Medicaid programs. In West Virginia, every 137.6 per 100 people have been prescribed an
opioid. A 2018 study focused on 119,605 live births in WV hospitals and discovered that 1,974
of the births were NAS diagnoses.
West Virginia has had the highest number of drug-addicted babies than any other state.
Several movements have taken place in West Virginia to fight the pediatric opioid endemic.
NAS Centers have offered pharmacological and nonpharmacological treatments to infants. Lily’s
Place opened in 2014 and was the first NAS center to open within the United States. Babies who
have gone through the withdrawal process have been treated at Lily’s Place while parents have
been taught the basics to care for an NAS infant.
Lily’s Place Executive Director, Rebecca Crowder, was interviewed via phone
conference. While Lily’s Place has been licensed to allow up to 16 babies at a time, the facility
has preferred no more than 14 babies to leave space for a set of twins. The average length of stay
for a Lily’s Place patient has been 30 days. Crowder stated that Lily’s Place has offered services
including medication and therapeutic handling to babies going through the withdrawal process.
Mothers have been provided peer support specialists and rooming-in, which has added to the
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recovery program already in place. Fathers and families have also been involved with treatment
plans including CPR, first aid, follow-up clinics, counselors, and social work. Crowder stated
that since opening in 2014, the number of neonatal patients has steadied out because the choice
of drugs has shifted and obvious, exposure symptoms have been different.
In 2012, the NTU opened in Huntington, West Virginia, at the Hoops Family Children’s
Hospital. When infants have not benefited from the services offered in the hospital NICU, the
NTU has been utilized to care for NAS babies. In 2012, hospital charges for NAS reached $1.5
billion. Prevention and treatment for NAS should have begun before, during, and after
pregnancy. The Drug Free Moms and Babies Program (DFMB) was established in West Virginia
with an ultimate goal of providing prevention, intervention, education and treatment to mothers
and infants.

Study Limitations
This study was limited due to the number of databases used for the secondary search,
restraints in the literature search strategy, and bias of the researchers. The study was focused on
NAS prevention, intervention, and treatment in West Virginia and detailed research for other
states was not included.

Practical Implications
NAS Centers have been established in West Virginia and have provided care to NAS
babies and mothers. West Virginia NAS Centers have become a model for other states that have
also battled the pediatric opioid endemic. Treatment models from Lily’s Place and other NAS
Centers within West Virginia have created a way for health care providers nationwide to care for
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NAS infants. The continued use of such models and prenatal opioid maintenance therapy will
decrease the NAS morbidity and cost of treatments.

CONCLUSION
The purpose of this research paper was that NAS Centers and prenatal opioid maintenance
therapy would help improve the pediatric opioid endemic by decreasing the number of NAS
patients and decrease the cost of treatments for infants. The review explored research and an
expert in NAS therapy was conducted. The results from this showed that NAS Centers offering
therapy to both mothers and patients, will decrease the amount of infants diagnosed with NAS
and decrease the cost of treatments.
PEDIATRIC OPIOID ENDEMIC
REFERENCES
Centers for Disease Control and Prevention (CDC). (2018). Opioid Basics. Retrieved January 16, 2020,
from https://www.cdc.gov/drugoverdose/opioids/index.html.
Cenziper, D., Corio, E., Hooper, K., Soule, D. (2019, October 18). Inside West Virginia’s Opioid Battle:
“They Looked At Us Like An Easy Target”. Retrieved January 16, 2020, from
https://www.washingtonpost.com/graphics/2019/investigations/west-virginia-opioid-legal-battlefoster-care/.
Congressional Research Service (CRS). (2016, May 11). H.R. 4978- NAS Healthy Babies Act. Retrieved
April 5, 2020, from https://www.congress.gov/bill/114th-congress/house-bill/4978.
Davis, C. (2016a, March 03). Lily’s Place Continuing to Care for Addicted Babies. WV Public
Broadcasting. Retrieved January 20, 2020, from https://www.wvpublic.org/post/lilys-placecontinuing-care-addicted-babies#stream/0.

15

Maynard, Urian-Watson

April, 2020

HCA 695- Draft 3

Davis, C. (2016b, July 26). Lily’s Place the Inspiration for Federal NAS Act. West Virginia Public
Broadcasting. Retrieved February 1, 2020, from https://www.wvpublic.org/post/lilys-placeinspiration-federal-nas-act#stream/0.
Gottlieb, J. D., Davies, T., Wright, S. (2018) Healthy Connections: Helping Families in West Virginia
Combat Opioid Addiction. Child Welfare League of America (CWLA). Retrieved January 17,
2020, from https://www.cwla.org/healthy-connections-helping-families-in-west-virginia-combatopioid-addiction/.
GovTrack.us. (2020). H.R. 5562 — 115th Congress: Protecting NAS Babies Act. Retrieved February 1,
2020, from https://www.govtrack.us/congress/bills/115/hr5562.
Greenbrier Valley Medical Center. (2020). Drug Free Moms and Babies- Greenbrier Valley. Retrieved
January 19, 2020 from https://www.gvmc.com/news-room/drug-free-moms-and-babiesgreenbrier-valley--14865.
Harold, Z. (2011, September 29). Many pregnant women abusing drugs. Gazette Mail. Retrieved January
19, 2020 from https://www.wvgazettemail.com/news/many-pregnant-women-abusingdrugs/article_563607da-af35-5cac-8d42-4fc59f93a4dc.html.
Hedegaard, H. Minino, A. Warner, M. (2020, January). Drug Overdose Deaths in the United States,
1999-2018. Retrieved April 5, 2020, from https://www.cdc.gov/nchs/data/databriefs/db356-h.pdf.
Hodousek, C. (2018, February 13). WV becomes first state to be recognized for NAS treatment centers.
Metro News. Retrieved January 19, 2020 from http://wvmetronews.com/2018/02/13/wv-becomesfirst-state-to-be-recognized-for-nas-treatment-centers/.
Hoops Children’s Hospital. (2020). Neonatal Therapeutic Unit. Retrieved February 1, 2020, from
http://hoopschildrens.org/facilities-programs/neonatal-therapeutic-unit/.
Knisely, A. F. (2019, November 13). Study: 54 out of every 1,000 WV children affected by opioid use,
will need $4B in services. The Gazette Mail. Retrieved January 19, 2020 from
https://wvperinatal.org/study-54-out-of-every-1000-wv-children-are-affected-by-opioid-use-willneed-4b-in-services/.

16

Maynard, Urian-Watson

April, 2020

HCA 695- Draft 3

Ko, J., Patrick, S.W.,Tong, V.T, Patel, R., Ling, J.N., Barfield, W.D. (2016). Incidence of Neonatal
Abstinence Syndrome- 28 States, 1999-2013. 12; 65(31): 799-802.
Krans, E. E., Cochran, G., & Bogen, D. L. (2015). Caring for Opioid-dependent Pregnant Women:
Prenatal and Postpartum Care Considerations. Clinical obstetrics and gynecology, 58(2), 370–
379.
Lilly, C. L., Ruhnke, A. M., Breyel, J., Umer, A., & Leonard, C. E. (2019, September 15). Drug Free
Moms and Babies: Qualitative and quantitative program evaluation results from a rural
Appalachian state. Preventive medicine reports 15, 100919.
Lee, K.G., Zieve, D., Conaway, B. (2020). Neonatal abstinence syndrome. Medline Plus Retrieved
January 19, 2020 from https://medlineplus.gov/ency/article/007313.htm.
Lexico. (2020). Definition of Endemic in English. Retrieved April 3, 2020, from
https://www.lexico.com/en/definition/endemic.
Morgan, P. L., Wang, Y. (2019, July 30). The Opioid Epidemic, Neonatal Abstinence Syndrome, and
Estimated Costs for Special Education Services. American Journal of Managed Care (AJMC).
Retrieved from https://www.ajmc.com/journals/supplement/2019/deaths-dollars-divertedresources-opioid-epidemic/opioid-epidemic-neonatal-abstinence-syndrome-estimated-costsspecial-education-services.
Murray, S. (2017, May 02). The Harm the Opioid Epidemic is Causing Families. Children’s Hospital
Association. Retrieved January 18, 2020, from
https://www.childrenshospitals.org/Newsroom/Childrens-Hospitals-Today/IssueArchive/Issues/Spring-2017/Articles/The-Harm-the-Opioid-Epidemic-is-Causing-Families.
Nair, V., Soraisham, A. S., & Akierman, A. (2012, May). Neonatal withdrawal syndrome due to maternal
codeine use. Paediatrics & child health, 17(5), e40–e41.
National Academy of Sciences (NAS). (2017). Trends in Opioid Use, Harms, and Treatment. Pain
Management and the Opioid Epidemic: Balancing Societal and Individual Benefits and Risks of

17

Maynard, Urian-Watson

April, 2020

HCA 695- Draft 3

Prescription Opioid Use. Retrieved January 16, 2020, from
https://www.ncbi.nlm.nih.gov/books/NBK458661/.
National Institute of Health (NIH). (2019, March). Opioid-Involved Overdose Deaths. West Virginia
Opioid Summary. Retrieved January 19, 2020, from https://www.drugabuse.gov/opioidsummaries-by-state/west-virginia-opioid-summary.
NgUyen, L., Lander, L. R., O’Grady, K.E., Marshalek, P.J., Schmidt, A., Kelly, A. K., Jones, H.E.
(2018). Brief Report: Treating Women with Opioid Use Disorder during Pregnancy in
Appalachia: Initial Neonatal Outcomes Following Buprenorphine + Naloxone Exposure. The
American Journal on Addictions 27(2,) 92-96.
Normile, B., Hanlon, C. (2018). WV Medicaid Covers an Innovative and Less Costly Treatment Model
for Opioid-Affected Infants. National Academy for State Health Policy (NASHP). Retrieved
January 19, 2020 from https://nashp.org/wv-medicaid-covers-an-innovative-and-less-costlytreatment-model-for-opioid-affected-infants/.
Null, J. (2018) Lily’s Place. Retrieved January 18, 2020, from http://www.wvexecutive.com/lilys-place/.
Patrick, S. W. (2019, March 6). Opioid-Dependent Newborns in My West Virginia Hometown Point to a
Path Out of Drug Crisis. The RAND Blog. Retrieved January 19, 2020 from
https://www.rand.org/blog/2019/03/opioid-dependent-newborns-in-my-west-virginiahometown.html.
Patrick, S. W., Davis, M. M., Lehmann, C. U., & Cooper, W. O. (2015, August). Increasing incidence and
geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. Journal of
perinatology: official journal of the California Perinatal Association, 35(8), 650–655.
Paulozzi, L. J., Mack, K. A., Hockenberry, J. M., & Centers for Disease Control and Prevention (CDC).
(2014, July 4). Vital signs: variation among States in prescribing of opioid pain relievers and
benzodiazepines - United States, 2012. Morbidity and mortality weekly report (MMWR), 63(26),
563–568.

18

Maynard, Urian-Watson

April, 2020

HCA 695- Draft 3

Powell, M. (2019, March 26). Helping Tiny People with Big Problems. Addiction Policy Forum.
Retrieved February 1, 2020, from https://www.addictionpolicy.org/blog/helping-tiny-peoplewith-big-problem.
Snoderly, J. (2018, March 12). Officials Hope Medicaid Funding Will Increase Treatment Options for
Opioid Exposed Infants. Retrieved February 1, 2020, from
https://www.wvnews.com/theet/news/officials-hope-medicaid-funding-will-increase-treatmentoptions-for-opioid/article_287c97ae-e8e5-5c7e-b02a-4599480eeed8.html.
Stabler, M. E., Long, D. L., Chertok, I. R. A., Giacobbi, P. R., Pilkerton, C., Lander, L. R. (2016).
Neonatal Abstinence Syndrome in West Virginia Substate Regions, 2007-2013. The Journal of
Rural Health 33(1) 92-101.
Stitely, M.L., Calhoun, B., Maxwell, S., Nerhood, R., Chaffin, D. (2010). Prevalence of drug use in
pregnant West Virginia patients. WV Medical Journal. 106(4) 48-52.
The Herald-Dispatch. (2018, May 01). Lily’s Place Receives Pfizer Grant. Retrieved February 1, 2020
from https://www.herald-dispatch.com/news/lily-s-place-receives-pfizer-grant/article_2a607a899ae5-5b4e-8778-fcacab05290d.html.
West Virginia Department of Health and Human Services (WVDHHR). (2018, February 13). DHHR
Receives CMS Approval for Neonatal Abstinence Syndrome Treatment Services. Retrieved
January 20, 2020, from https://dhhr.wv.gov/bms/News/Pages/DHHR-Receives-CMS-Approvalfor-Neonatal-Abstinence-Syndrome-Treatment-Services.aspx.
West Virginia Department of Health and Human Services (WVDHHR). (2019). Chapter 540 Neonatal
Abstinence Syndrome Center Services. Bureau for Medical Services (BMS) Provider Manual.
Retrieved January 20, 2020, from
https://dhhr.wv.gov/bms/Public%20Notices/Documents/BMS_Proposed_NASC%20Services%20
Policy%2003.22.19FinalApprovedPublicComment.pdf.

19

Maynard, Urian-Watson

April, 2020

HCA 695- Draft 3

Wiegand, S. L., Stringer, E. M., Stuebe, A. M., Jones, H., Seashore, C., Thorp, J. (2015). Buprenorphine
and Naloxone Compared With Methadone Treatment in Pregnancy. Obstetrics and Gynecology
125(2) 363-368.
Wolf, E. R., Tong, S. T., Sabo, R. T., Woolf, S. H., Abbinanti, K., Pecsok, J., Krist, A. H. (2019, October
23). A State-Level Study of Opioid Use Disorder Treatment Access and Neonatal Abstinence
Syndrome. Retrieved February 20, 2020, from
https://bmcpediatr.biomedcentral.com/articles/10.1186/s12887-019-1718-x.
Yao, W., Chu, C. H., & Li, Z. (2010, June). The use of RFID in healthcare: Benefits and barriers. In
RFID-Technology and Applications (RFID-TA), 2010 IEEE International Conference on (pp.
128-134). IEEE.

FIGURES/TABLES

20

Maynard, Urian-Watson

April, 2020

HCA 695- Draft 3

Figure 1. Conceptual research framework. Source: (Morgan and Wang, 2019).
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Figure 2. PRISMA- Overview of Literature Evaluation.
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APPENDIX
This research paper will include a semi-structured interview with Lily’s Place Executive
Director, Rebecca Crowder.
1.

What treatments are available at Lily's Place for babies going through the

withdrawal process?
2.

How many patients can be enrolled at once? Why? Why not?

3.

What specific treatments and/or programs are offered to mothers? Why?

4.

Compared to when Lily's Place opened in 2014, how much of an increase have you

seen in neonatal patients? Why?
5.

How does Lily's Place adapt to the increasing needs of patients? Why?

6.

How has Huntington's pediatric opioid endemic and Lily's Place helped create a

replication plan? Why?
7.

What is the average length of stay for a Lily's Place patient? Why?

8.

As executive director, what techniques do you utilize to lead your team members

and fulfill the Lily's Place mission? Why?
9.

What are the requirements of the patient's guardian to receive guardianship? Why?

10. Are families involved in Lily’s place after treatment? Why? Why not?
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11. If a patient’s parent does not want to keep guardianship, does Lily’s place facilitate
adoptions? Why? Why not?
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